Special Product's Line

Special Product's Line (SPL) is a specialized Italian pharmaceutical company that provides integrated services in the development and manufacturing of pharmaceutical products. Based in Pomezia, the company operates as a Contract Development and Manufacturing Organization (CDMO) with a strong focus on complex oral and injectable formulations. SPL maintains its own portfolio of branded and generic medicines across therapeutic areas such as oncology, neurology, and cardiovascular health. The company's facilities are EU-GMP certified, supporting the production of a wide range of dosage forms including solids, liquids, and sterile injectables. In 2022, SPL was acquired by GHO Capital, a leading specialist healthcare investment firm, to support its expansion into international markets and enhance its technical capabilities.